Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
CardioRenal Medicine is Scopus-indexed (Q1, CiteScore 4.6), WoS SCIE, DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1664-3828Verify ISSN ↗1664-5502Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 22 / 88 | 75th | Q1 |
| Urology | 31 / 123 | 75th | Q1 |
| Cardiology and Cardiovascular Medicine | 119 / 409 | 71st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011 (also 2013–present), best quartile Q1, CiteScore 4.6.
CardioRenal Medicine is Q1 in Nephrology (rank 22 of 88), Q1 in Urology (rank 31 of 123) and Q2 in Cardiology and Cardiovascular Medicine (rank 119 of 409), by CiteScore 2025.
CardioRenal Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.856, quartile Q1, with an H-index of 35.
CardioRenal Medicine is published by S. Karger AG. Its print ISSN is 1664-3828 and its online ISSN is 1664-5502.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
CardioRenal Medicine has an h-index of 47 and a 2-year mean of 3.57 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q1. On 2-year citations it ranks #6 of 87 Scopus journals in Nephrology.
CardioRenal Medicine published 53 papers in 2025; its busiest recent year was 2024 with 62. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from China (30.8%), United States (17.1%) and Spain (10.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.